![Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors | Journal of Clinical Oncology Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2014.59.33.issue-2/jco.2014.55.5409/20161107/images/medium/zlj00215-4672-t05.jpeg)
Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors | Journal of Clinical Oncology
![Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors | Journal of Clinical Oncology Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2014.59.33.issue-2/jco.2014.55.5409/20161107/images/medium/zlj00215-4672-t04.jpeg)
Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors | Journal of Clinical Oncology
![COST-EFFECTIVENESS OF A MODIFIED CARE PROTOCOL SUBSTITUTING BLADDER TUMOR MARKERS FOR CYSTOSCOPY FOR THE FOLLOWUP OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A DECISION ANALYTICAL APPROACH | Journal of Urology COST-EFFECTIVENESS OF A MODIFIED CARE PROTOCOL SUBSTITUTING BLADDER TUMOR MARKERS FOR CYSTOSCOPY FOR THE FOLLOWUP OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A DECISION ANALYTICAL APPROACH | Journal of Urology](https://www.auajournals.org/cms/asset/5605d331-ab31-4433-adcc-71f15bea5379/gr3.gif)
COST-EFFECTIVENESS OF A MODIFIED CARE PROTOCOL SUBSTITUTING BLADDER TUMOR MARKERS FOR CYSTOSCOPY FOR THE FOLLOWUP OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A DECISION ANALYTICAL APPROACH | Journal of Urology
![Tumor marker usage and medical care costs among older early-stage breast cancer survivors. | Semantic Scholar Tumor marker usage and medical care costs among older early-stage breast cancer survivors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/809af174a3a561f4504e5160d3f0350e1a69624c/4-Table2-1.png)
Tumor marker usage and medical care costs among older early-stage breast cancer survivors. | Semantic Scholar
![Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments | Molecular Cancer | Full Text Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-022-01543-7/MediaObjects/12943_2022_1543_Fig1_HTML.png)
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments | Molecular Cancer | Full Text
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting](https://www.frontiersin.org/files/MyHome%20Article%20Library/479117/479117_Thumb_400.jpg)
Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
![Tumor marker usage and medical care costs among older early-stage breast cancer survivors. | Semantic Scholar Tumor marker usage and medical care costs among older early-stage breast cancer survivors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/809af174a3a561f4504e5160d3f0350e1a69624c/3-Table1-1.png)
Tumor marker usage and medical care costs among older early-stage breast cancer survivors. | Semantic Scholar
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure2.gif)